Kv1.3 Therapeutics, Inc.
Biotechnology company · Seattle, Washington, United States
Kv1.3 Therapeutics, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $168,182 sold in a notice filed in 2018.
Kv1.3 Therapeutics at a glance
What does Kv1.3 Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $168,182 sold (2018).
Frequently asked questions about Kv1.3 Therapeutics
Where is Kv1.3 Therapeutics headquartered?
Kv1.3 Therapeutics, Inc. is headquartered in Seattle, Washington, United States.
What does Kv1.3 Therapeutics do?
Kv1.3 Therapeutics, Inc. is a biotechnology company.
When was Kv1.3 Therapeutics founded?
The earliest incorporation on record for Kv1.3 Therapeutics, Inc. is in 2017, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences